WO2007038425A3 - Anti-viral compouinds - Google Patents

Anti-viral compouinds Download PDF

Info

Publication number
WO2007038425A3
WO2007038425A3 PCT/US2006/037241 US2006037241W WO2007038425A3 WO 2007038425 A3 WO2007038425 A3 WO 2007038425A3 US 2006037241 W US2006037241 W US 2006037241W WO 2007038425 A3 WO2007038425 A3 WO 2007038425A3
Authority
WO
WIPO (PCT)
Prior art keywords
viral
compouinds
compounds
administering
animal
Prior art date
Application number
PCT/US2006/037241
Other languages
French (fr)
Other versions
WO2007038425A2 (en
Inventor
David M Ferguson
John Goodell
Original Assignee
Univ Minnesota
David M Ferguson
John Goodell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota, David M Ferguson, John Goodell filed Critical Univ Minnesota
Publication of WO2007038425A2 publication Critical patent/WO2007038425A2/en
Publication of WO2007038425A3 publication Critical patent/WO2007038425A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

The invention provides anti-viral compounds of formula (I) wherein R1-R3 and A have any of the values defined herein. The invention also provides pharmaceutical compositions comprising such compounds as well as methods for treating viral infections by administering such compounds to an animal.
PCT/US2006/037241 2005-09-27 2006-09-26 Anti-viral compouinds WO2007038425A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72100205P 2005-09-27 2005-09-27
US60/721,002 2005-09-27

Publications (2)

Publication Number Publication Date
WO2007038425A2 WO2007038425A2 (en) 2007-04-05
WO2007038425A3 true WO2007038425A3 (en) 2007-10-25

Family

ID=37900358

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/037241 WO2007038425A2 (en) 2005-09-27 2006-09-26 Anti-viral compouinds

Country Status (1)

Country Link
WO (1) WO2007038425A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100137394A1 (en) 2007-04-30 2010-06-03 Grenentech, Inc. Pyrazole inhibitors of wnt signaling
PE20110598A1 (en) 2008-10-02 2011-08-31 Respivert Ltd INHIBITORS OF MITOGEN P38 ACTIVATED PROTEIN KINASE ENZYMES
GB0818033D0 (en) 2008-10-02 2008-11-05 Respivert Ltd Novel compound
KR20110094127A (en) 2008-12-11 2011-08-19 레스피버트 리미티드 P38 map kinase inhibitors
CA2658259A1 (en) * 2009-03-12 2010-09-12 Institut Pasteur Dengue virus-like particle and uses thereof
GB0905955D0 (en) 2009-04-06 2009-05-20 Respivert Ltd Novel compounds
CN103827091B (en) * 2011-07-01 2016-05-18 默克专利有限公司 The purposes of pyrazoline, its pharmaceutical composition and treatment growing barrier thereof
US9199975B2 (en) 2011-09-30 2015-12-01 Asana Biosciences, Llc Biaryl imidazole derivatives for regulating CYP17
US8809372B2 (en) 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
CN106632278A (en) * 2016-12-16 2017-05-10 黄子为 Heterocyclic nitrogen compound and application thereof
WO2020209898A1 (en) 2019-04-12 2020-10-15 Stryker Corporation Manifold for a medical waste collection system
WO2023081312A1 (en) * 2021-11-04 2023-05-11 Vir Biotechnology, Inc. Small molecule inducers of autophagy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3837851A (en) * 1973-01-15 1974-09-24 Ibm Photoconductor overcoated with triarylpyrazoline charge transport layer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3837851A (en) * 1973-01-15 1974-09-24 Ibm Photoconductor overcoated with triarylpyrazoline charge transport layer

Also Published As

Publication number Publication date
WO2007038425A2 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
WO2007038425A3 (en) Anti-viral compouinds
MX2020001453A (en) Anti parasitic dihydroazole compounds and compositions comprising same.
WO2008005565A3 (en) Antiviral phosphinate compounds
WO2009111653A3 (en) Antiviral therapeutic agents
WO2009005677A3 (en) Antiviral compounds
WO2009005676A3 (en) Antiviral compounds
EP2041159B8 (en) Macrocyclic compounds as antiviral agents
WO2009152356A3 (en) Compounds and compositions useful for the treatment of malaria
WO2009026179A3 (en) Antiinfective proanthocyanidin compounds and methods of use thereof
TW200639169A (en) Bicyclic heteroaryl derivatives for treating viruses
WO2009046314A3 (en) Moenomycin analogs, methods of synthesis, and uses thereof
WO2008013838A3 (en) Pyridizinone derivatives
WO2007112028A3 (en) 2'-fluoronucleoside phosphonates as antiviral agents
GEP20156263B (en) Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for production and usage thereof
WO2010029302A3 (en) Compounds for treating viral infections
WO2008057208A3 (en) Hcv ns3 protease inhibitors
WO2008051514A3 (en) Hcv ns3 protease inhibitors
WO2008051475A3 (en) Hcv ns3 protease inhibitors
WO2007090623A3 (en) Fungicidal compositions
EA200802058A1 (en) DERIVATIVES OF CYCLO-ALKYLAMINO ACIDS AND THEIR PHARMACEUTICAL COMPOSITIONS
WO2010057101A3 (en) Compounds useful as hiv blockers
WO2008021927A3 (en) Hepatitis c virus inhibitors
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
WO2008115281A3 (en) Compounds for treating viral infections
WO2008051477A3 (en) Hcv ns3 protease inhibitors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06815326

Country of ref document: EP

Kind code of ref document: A2